|
PL346951A1
|
|
Method of obtaining hemin and its lower alkyl esters
|
|
PL343910A1
|
|
Pharmacological agent for external application
|
|
PL340775A1
|
|
Pharmacological agent for local application in treating parodontium diseases
|
|
PL332782A1
|
|
Pharmaceutic preparation
|
|
PL193090B1
|
|
Method of obtaining an ubiquitin complex exhibiting biological activity
|
|
PL193089B1
|
|
Method of obtaining an ubiquitin complex exhibiting biological activity
|
|
PL193091B1
|
|
Method of obtaining an ubiquitin complex exhibiting biological activity
|
|
PL332119A1
|
|
Method of obtaining an ubiquitin complex exhibiting biological activity
|
|
PL331905A1
|
|
Method of obtaining p-chlorophenylamide of 3-methyl-5-benzoylamino isothiazolo-4-carboxylic acid
|
|
PL327698A1
|
|
Pharmaceutic preparation in the form of a sucking tablet
|
|
PL326434A1
|
|
Pharmaceutical composition and method of manufacturing of the pharmaceutical composition
|
|
PL324443A1
|
|
Method of obtaining propylthiouracil
|
|
PL321166A1
|
|
Ophtalmic suspension and method of preparing same
|
|
PL315723A1
|
|
Method of obtaining 3-hydroxy-3-phenyl-n-methyl propyloamine
|
|
PL313987A1
|
|
Fluoxetin obtained method
|
|
PL309500A1
|
|
Method of obtaining alkyl 3-methyl-5-caroxyethoxyaminoisothiazolo-4-carboxylic esters
|
|
PL305076A1
|
|
Method of obtaining hyaluronidaze
|
|
PL304563A1
|
|
Method of obtaining d-/-/-s-acetyl-3-mercapto-2-methylopropionic chloride
|
|
PL301549A1
|
|
Method of obtaining alpha-(4-nitrophenyl)alkyl carboxylic esters
|
|
PL299726A1
|
|
Method of purifying 3-methyl-5-benzoiloaminotriazole-4 carboxylic p-chlorophenylamide
|
